1. Risk stratification through extensive allergy work‐up in COVID‐19‐mRNA vaccine allergic reactions.
- Author
-
Soria, Angèle, Labella, Marina, Doña, Inmaculada, Nicaise‐Roland, Pascale, Chollet‐Martin, Sylvie, Autegarden, Jean‐Eric, Castagna, Julie, Le Thai, Claire, de Chaisemartin, Luc, Torres, Maria José, and Barbaud, Annick
- Subjects
- *
ALLERGIES , *VACCINES , *ANAPHYLAXIS , *SKIN tests , *POLYETHYLENE glycol - Abstract
In 145 patients, revaccination was performed with the culprit vaccine, which was well tolerated in 126 of the patients, and 15 of the patients had an alternative COVID-19 vaccine (other mRNA vaccine for 12), which was well tolerated in 13 of the patients (Figure 1). Keywords: allergy; anaphylaxis; COVID-19-mRNA vaccines EN allergy anaphylaxis COVID-19-mRNA vaccines 2320 2323 4 08/02/23 20230801 NES 230801 To the Editor, The mechanisms of allergic reactions to COVID-19-mRNA vaccines have not been elucidated. One hundred and sixty patients (84%) were revaccinated (122 under antihistamine premedication), 139 patients (87%) had good tolerance, and 30 patients refused further COVID-19 vaccination. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF